ICL Central Research and Development Institute (IMI Tami) has received the “Golden Mark” award from the Standards Institution of Israel. This is a certificate provided to organizations committed to quality and excellence, which have three or four quality standard marks testifying to the conformity of their management systems, processes and products, with Israeli and International standards. ICL Central R&D Inst. operates in full compliance with ISO 9001, ISO 14001 and OSHAS 18001. This award recognizes the continuing efforts of the ICL R&D Institute as a company that maintains its quality management system at the highest level in order to provide its clients with an optimal service.
This award, for quality management, environmental management and safety management, complements the compliance of the institute with the Responsible Care guidelines and the operation of the service laboratories under the strict quality standards of ISO 17025/GMP/GLP, and with the international recognition of the ICL R&D Inst. by the United States Food and Drug Administration (FDA).